candesartan cilexetil has been researched along with D-fructopyranose in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashiura, K; Hirata, A; Iimura, O; Masuda, A; Matsuda, K; Miyazaki, Y; Nakagawa, M; Shimamoto, K; Takizawa, H; Ura, N | 1 |
Higashiura, K; Iimura, O; Matsuda, K; Shimamoto, K; Takizawa, H; Ura, N | 1 |
Fujioka, Y; Higaki, J; Ikegami, H; Kawaguchi, N; Kobayashi, R; Mikami, H; Nagano, M; Nakamura, F; Ogihara, T; Onishi, S | 1 |
Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I | 1 |
Chen, S; Izumida, T; Katayama, S; Noguchi, Y; Tatebe, J | 1 |
Jiang, HY; Kawata, Y; Koike, T; Li, P; Oshida, Y; Wang, ZH | 1 |
Hashikawa, N; Hashikawa-Hobara, N; Inoue, Y; Kawasaki, H; Sanda, H; Takatori, S; Zamami, Y | 1 |
Dudhipala, N; Veerabrahma, K | 1 |
1 trial(s) available for candesartan cilexetil and D-fructopyranose
Article | Year |
---|---|
Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diet; Fructose; Glucose Clamp Technique; Humans; Hypertension; Indans; Insulin Resistance; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
7 other study(ies) available for candesartan cilexetil and D-fructopyranose
Article | Year |
---|---|
Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
Topics: Angiotensin Receptor Antagonists; Animal Feed; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Fructose; Insulin Resistance; Male; Prodrugs; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Fructose; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Tetrazoles | 1993 |
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Child; Diet; Fructose; Glucose; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles | 1996 |
A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Captopril; Chromans; Diet; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar; Tetrazoles; Thiazoles; Thiazolidinediones; Troglitazone | 1996 |
Acute treatment with candesartan cilexetil, an angiotensin II type 1 receptor blocker, improves insulin sensitivity in high-fructose-diet-fed rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Humans; Insulin Resistance; Male; Muscle, Skeletal; Rats; Rats, Wistar; Tetrazoles | 2012 |
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Fructose; Gene Expression Regulation; Insulin; Insulin Resistance; Neurites; Nociception; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptor, Angiotensin, Type 2; Signal Transduction; Tetrazoles | 2012 |
Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biological Availability; Biphenyl Compounds; Blood Pressure; Calorimetry, Differential Scanning; Crystallography, X-Ray; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Stability; Fructose; Hypertension; Lipids; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Powder Diffraction; Rats, Wistar; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical; Tetrazoles; Ultrasonics | 2016 |